Genflow Biosciences secures £715,000 funding for gene therapy research
ACCESSWIRE - 04-Apr-2024Company aims to target age-related diseases and liver disease NASH
Join the club for FREE to access the whole archive and other member benefits.
News platform
News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.
We are the communications partner for all your Investor Relations and Public Relations needs. Our comprehensive solutions are used by thousands of customers, from emerging startups to multi-billion dollar global brands, ensuring their most important moments are reaching the right audiences via our industry-leading newswire service, IR website solutions, events technology and compliance solutions.
Visit website: https://www.accesswire.com
Details last updated 28-Apr-2024
Company aims to target age-related diseases and liver disease NASH